Co-ordinating Centre: National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland.
Discipline of Medicine, Clinical Science Institute, National University of Ireland Galway, University Road, Galway, Ireland, H91 TK33.
Curr Cardiol Rep. 2021 Aug 19;23(10):136. doi: 10.1007/s11886-021-01568-2.
To describe the INTERASPIRE scientific protocol-an international survey of secondary prevention of coronary heart disease (CHD).
This international survey is being conducted through National Societies of Cardiology in selected countries from each of the six WHO regions and has the following overall aims: (i) describe prevalence of cardiometabolic and renal risk factors together with biomarkers in CHD patients; (ii) describe current risk factor management through lifestyle changes and cardioprotective drug therapies; (iii) provide an objective assessment of clinical implementation of preventive care by comparison with the lifestyle and risk factor targets defined in international and national guidelines; (iv) investigate the reasons for variation in preventive cardiology practice between regions and countries; and (v) promote the principles of best preventive cardiology practice. This international survey will provide a unique picture of CHD patients; their cardiometabolic, renal and biomarker status; lifestyle and therapeutic management; and the quality of preventive care provided in all WHO regions.
描述 INTERASPIRE 科学方案——一项针对冠心病(CHD)二级预防的国际调查。
这项国际调查正在通过世界卫生组织六个区域的每个区域的各国心脏病学会进行,具有以下总体目标:(i)描述 CHD 患者中心血管代谢和肾脏危险因素以及生物标志物的流行情况;(ii)通过生活方式改变和心脏保护药物治疗描述当前的危险因素管理情况;(iii)通过与国际和国家指南中定义的生活方式和危险因素目标进行比较,对预防保健的临床实施情况进行客观评估;(iv)调查不同地区和国家之间预防心脏病学实践差异的原因;(v)促进最佳预防心脏病学实践的原则。这项国际调查将提供一个独特的 CHD 患者画面;他们的心血管代谢、肾脏和生物标志物状况;生活方式和治疗管理;以及在所有世界卫生组织区域提供的预防保健质量。